RU2013158422A - METHOD FOR REMOVING TUMOR NECROSIS FACTOR FROM BIOLOGICAL LIQUIDS USING MAGNETIC CONTROLLED GRANULES - Google Patents
METHOD FOR REMOVING TUMOR NECROSIS FACTOR FROM BIOLOGICAL LIQUIDS USING MAGNETIC CONTROLLED GRANULES Download PDFInfo
- Publication number
- RU2013158422A RU2013158422A RU2013158422/14A RU2013158422A RU2013158422A RU 2013158422 A RU2013158422 A RU 2013158422A RU 2013158422/14 A RU2013158422/14 A RU 2013158422/14A RU 2013158422 A RU2013158422 A RU 2013158422A RU 2013158422 A RU2013158422 A RU 2013158422A
- Authority
- RU
- Russia
- Prior art keywords
- necrosis factor
- tumor necrosis
- magnetic controlled
- biological liquids
- removing tumor
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Способ снижения содержания фактора некроза опухоли, включающий пропускание биологических жидкостей через гранулированный препарат с иммобилизированными антителами к фактору некроза опухоли, отличающийся тем, что для иммобилизации антител к фактору некроза опухоли используют полиакриламидный носитель с магнитными свойствами при соотношении носитель : железо 2:1, который гранулируют методом эмульсионной полимеризации.A method of reducing the content of tumor necrosis factor, including passing biological fluids through a granular preparation with immobilized antibodies to tumor necrosis factor, characterized in that a polyacrylamide carrier with magnetic properties is used to immobilize antibodies to the tumor necrosis factor with a carrier: iron ratio of 2: 1, which is granulated emulsion polymerization method.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2013158422/14A RU2013158422A (en) | 2013-12-26 | 2013-12-26 | METHOD FOR REMOVING TUMOR NECROSIS FACTOR FROM BIOLOGICAL LIQUIDS USING MAGNETIC CONTROLLED GRANULES |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2013158422/14A RU2013158422A (en) | 2013-12-26 | 2013-12-26 | METHOD FOR REMOVING TUMOR NECROSIS FACTOR FROM BIOLOGICAL LIQUIDS USING MAGNETIC CONTROLLED GRANULES |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2013158422A true RU2013158422A (en) | 2015-07-10 |
Family
ID=53538073
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2013158422/14A RU2013158422A (en) | 2013-12-26 | 2013-12-26 | METHOD FOR REMOVING TUMOR NECROSIS FACTOR FROM BIOLOGICAL LIQUIDS USING MAGNETIC CONTROLLED GRANULES |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2013158422A (en) |
-
2013
- 2013-12-26 RU RU2013158422/14A patent/RU2013158422A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR107988A1 (en) | METHODS OF USE OF SUPERABSORBENT POLYMERS FOR ARENA FRACTURE AND CONTROL APPLICATIONS | |
SA522431756B1 (en) | Antibodies to Tigit | |
MX2017004311A (en) | Glucocorticoid-induced tumor necrosis factor receptor (gitr) antibodies and methods of use thereof. | |
EA201291230A1 (en) | METHODS RELATED TO APPLICATION OF LIQUIDS WITH HIGH CONTENT OF SOLID PHASE IN OIL INDUSTRY | |
EA201600252A1 (en) | MODIFIED ANTIBODIES TO RECEPTORS OF ANTIEPIDERMAL GROWTH FACTOR AND METHODS FOR THEIR USE | |
EA201300978A1 (en) | ANTIBODIES TO CEA | |
EA201791139A1 (en) | HETERODIMERNYE ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS | |
EA201492101A1 (en) | ANTIBODIES AGAINST FCRN | |
MX2015011957A (en) | Anti-tnf-anti-il-17 bispecific antibodies. | |
MX359794B (en) | Anti-hepcidin antibodies and uses thereof. | |
EA201790882A1 (en) | METHODS AND COMPOSITIONS FOR LIVER CANCER THERAPY | |
EA201690958A1 (en) | DEPRESSANTS FOR USE IN DIVISION METHODS | |
CL2016002257A1 (en) | Anti-mcam antibodies and associated methods of use | |
EA201391312A1 (en) | ANTIBODY TO THE HUMAN TISSUE FACTOR AND ITS APPLICATION | |
PH12015502601A1 (en) | ANTI-TNF-a/CXCL10 DOUBLE-TARGETING ANTIBODY AND USE THEREOF | |
EA201590420A1 (en) | METHOD FOR REMOVAL OF HYDROGEN AND / OR SULFHYDRYL COMPOUNDS | |
MA44061A (en) | MULTISPECIFIC ANTIBODY MOLECULES WITH SPECIFICITY FOR TNF-ALPHA, IL-17A AND IL-17F | |
UA116008C2 (en) | Pan-ELR+ CXC CHEMOKINE ANTIBODIES | |
EA201491004A1 (en) | APPLICATION OF PARTICLES WITH NEUTRAL DENSITY FOR ENHANCING THE RESISTANCE TO THE BARITIS SEDUCTION OF TRANSPORT AND FLUID SUSPENSIONS | |
EA201690036A1 (en) | COMPOSITION WITH EXTENDED GRIPPING, CONTAINING CYTEHAMINE GRANULES AND METHODS FOR ITS PREPARATION AND APPLICATION | |
GEP20217307B (en) | ANTI-TNFα-ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF | |
EA201690992A1 (en) | ANTIBODIES SPECIFIC TO FCRN | |
MX2016006743A (en) | Spr-based bridging assay for determining the biological activity of multivalent, multispecific molecules. | |
EA201591720A1 (en) | PROTEINS SPECIFIC IN RELATION TO BAFF AND B7RP1, AND THEIR APPLICATION | |
WO2015138928A3 (en) | Mixed mode ligands |